136
cesses will lead to a better staging protocol and a more tailor-made
treatment for the patient. On this topic we did a review of litera-
ture and we will propose a hypothesis that might lead to a better
understanding of OSCC invading bone.
http://dx.doi.org/10.1016/j.ijom.2017.02.471Treatment of advanced-stage squamous cell carcinoma of the
head and neck
Y.F. Wang
∗
, H.Y. Yang
Peking University Shenzhen Hospital, China
Background:
The treatment of advanced oral cancer is always a
difficult point.
Objectives:
The aim of this study was to evaluate the usefulness
of salvage surgery by survival rates and life quality in patients with
advanced oral squamous cell carcinoma (OSCC).
Methods:
32 patients with advanced OSCC at stage III or IV
who had received radiotherapy and regular follow-up after sal-
vage combined radical surgery and simultaneous repair between
January 2014 and November 2015 were included in the study. All
patients underwent an interview survey and self-assessment based
on the Chinese version of the University of Washington Quality of
Life Questionnaire (4th edition). Pain, appearance, action, recre-
ation, swallow, chew, language, shoulder function, taste, saliva,
emotion and anxiety were included in this questionnaire.
Findings:
No severe complications occurred and median follow-
up time was 12 months with 100% overall survival, one case
with cervical metastatic, one case with relapses were included.
The quality of life after surgery was pretty much lower, mostly
in swallow, chew, the production of saliva, taste alteration and
defects which made an enormously negative impact on the phys-
iology, emotion, social function and postoperative quality of life
of patients. Simultaneous functional reconstruction improved the
appearance, communication, general condition of patients, which
assisted other treatments like radiotherapy.
Conclusion:
Salvage and radical surgery based sequential com-
bined treatment is an effective treatment program, make a
significant sense to increase the survival rates and functional
reconstruction also improve the quality of life.
http://dx.doi.org/10.1016/j.ijom.2017.02.472Oral propranolol combined with topical timolol maleate for
the treatment of severe infantile mixed haemangioma in
parotid region
X.K. Wang
School of Stomatology, China Medical University, China
Objective:
To investigate the clinical results and safety of oral
propranolol combined with topical timolol maleate for the man-
agement of severe infantile mixed haemangioma in parotid region.
Methods:
Between October 2012 and June 2014, 52 infants with
severe parotid mixed haemangiomas were treated with a combi-
nation of oral propranolol and topical timolol maleate. All lesions
were also administrated using topically timolol maleate in every
12 h. The therapy duration was planned for 6–8 months or the
two drugs were stopped when complete regression of lesions was
obtained. The blood pressure, heart rate values, and adverse events
were recorded during hospitalisation. The electrocardiogram was
reviewed one month after discharge. The therapeutic outcomes
and safety were assessed by the changes of color, size of tumour,
and adverse effects throughout the course of treatment.
Results:
The mean therapy duration was 5.3 months (range, 3–8
months). Of 52 patients, 37 demonstrated excellent response, 15
showed good response. There was no significant decrease respec-
tively in the mean systolic and diastolic blood pressures and the
mean heart rate from pretreatment to post-treatment (all
P
> 0.05).
The decrease of cardiovascular parameters were not commonly
associated with observable clinical symptoms. No major collateral
effects were observed.
Conclusions:
Oral propranolol combined with topical timolol
maleate are highly effective in the treatment of infantile parotid
mixed haemangioma with minor side effects, and might be used
as the first-line treatment selection.
http://dx.doi.org/10.1016/j.ijom.2017.02.473An alternative management of the pathological fracture in
osteoradionecrosis
C. Wanis
∗
, S. Nathwani, R. Bunyan
Luton and Dunstable University Hospital Foundation Trust,
United Kingdom
Background:
Osteoradionecrosis (ORN) is a known complication
following therapeutic radiotherapy (RT) in head and neck patients.
ORN was first described by Marx in 1983 as hypovascularity,
hypocellularity, and local tissue hypoxia as a result of radiation
injury
. 1Methods:
A case report of a 63-year-old male patient with an
ulcerative lesion in the left floor of the mouth. Clinically, histo-
logically and radiographically the lesion represented a T4 N0 M0
SCC. In light of the histological grading of the tumour, and his
immunosuppressed status, adjuvant radiotherapy was instigated
postoperatively.
The patient received implants in the mandible for oral reha-
bilitation. Three years following RT, he developed a pathological
fracture in the left body of mandible. The patient was on the Dela-
nian regime and no surgery was planned due to risks of poor
healing. Instead the implants previously placed in the mandible
were used as external fixation holding the fractured mandible in a
stable position to aid healing.
Results:
The mandibular implants, which coincidentally were on
either side of the fracture, were used to support a splint (kept out
of occlusion) spanning over the fracture site. This stabilised the
fracture site and allowed for complete healing of the fracture.
Conclusion:
This case shows an alternative management of a
pathological fracture. This allowed a medically compromised,
immunosuppressed patient with Grade III ORN to avoid hard tis-
sue graft surgery, and allowed for bony healing of a pathological
fracture.
Reference
Marx, R. E. (1983). Osteoradionecrosis: a new concept of its pathophysiol-
ogy.
J Oral Maxillofac Surg
,
41
, 283–288.
http://dx.doi.org/10.1016/j.ijom.2017.02.474




